Mepacrine

This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Mepacrine" – news · newspapers · books · scholar · JSTOR (August 2024) (Learn how and when to remove this message)

Mepacrine

Clinical data
Trade names	Atabrine, Atebrin
AHFS/Drugs.com	Micromedex Detailed Consumer Information
ATC code	P01AX05 (WHO) QP51AX04 (WHO)
Pharmacokinetic data
Protein binding	80–90%
Elimination half-life	5–14 days
Identifiers
IUPAC name (RS)-N′-(6-Chloro-2-methoxy-acridin-9-yl)-N,N-diethylpentane-1,4-diamine
CAS Number	83-89-6 Y
PubChem CID	237
DrugBank	DB01103 Y
ChemSpider	232 Y
UNII	H0C805XYDE
KEGG	D08179
ChEBI	CHEBI:8711 Y
ChEMBL	ChEMBL7568 Y
PDB ligand	QUN (PDBe, RCSB PDB)
CompTox Dashboard (EPA)	DTXSID7022627
ECHA InfoCard	100.001.371
Chemical and physical data
Formula	C23H30ClN3O
Molar mass	399.96 g·mol−1
3D model (JSmol)	Interactive image
SMILES CCN(CC)CCCC(C)Nc1c2ccc(cc2nc3c1cc(cc3)OC)Cl
InChI InChI=1S/C23H30ClN3O/c1-5-27(6-2)13-7-8-16(3)25-23-19-11-9-17(24)14-22(19)26-21-12-10-18(28-4)15-20(21)23/h9-12,14-16H,5-8,13H2,1-4H3,(H,25,26) Y Key:GPKJTRJOBQGKQK-UHFFFAOYSA-N Y
(verify)

Mepacrine, also called quinacrine or by the trade names Atabrine or Atebrin, is a medication with several uses. It is related to chloroquine and mefloquine. Although formerly available from compounding pharmacies, as of August 2020 it is totally unavailable in the United States.^[1]